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Flexibility and mobility 
of SARS‑CoV‑2‑related protein 
structures
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The worldwide CoVid‑19 pandemic has led to an unprecedented push across the whole of the scientific 
community to develop a potent antiviral drug and vaccine as soon as possible. Existing academic, 
governmental and industrial institutions and companies have engaged in large‑scale screening of 
existing drugs, in vitro, in vivo and in silico. Here, we are using in silico modelling of possible SARS‑
CoV‑2 drug targets, as deposited on the Protein Databank (PDB), and ascertain their dynamics, 
flexibility and rigidity. For example, for the SARS‑CoV‑2 spike protein—using its complete homo‑
trimer configuration with 2905 residues—our method identifies a large‑scale opening and closing of 
the S1 subunit through movement of the S B domain. We compute the full structural information of 
this process, allowing for docking studies with possible drug structures. In a dedicated database, we 
present similarly detailed results for the further, nearly 300, thus far resolved SARS‑CoV‑2‑related 
protein structures in the PDB.
At the end of 2019 a cluster of pneumonia cases was discovered in Wuhan city in China, which turned out to be 
caused by a novel coronavirus, SARS-CoV-21. Since then the virus has spread around the world and currently has 
caused over 75 million infections with nearly 1.7 million deaths worldwide (Dec 21, 2020)2. SARS-CoV-2 is the 
seventh identified coronavirus that causes human disease. Four of these viruses cause infections similar to the 
common cold and three, SARS-CoV, MERS-CoV and SARS-CoV-2 cause infections with high mortality  rates3. 
As well as affecting humans, coronaviruses also cause a number of infections in farm animals and  pets4. The risk 
of future cross-species transmission, especially from bats, has the potential to lead to future  pandemics5. Thus, 
there is an urgent need to develop drugs to treat infections and a vaccine to prevent this disease. Some success 
has already been achieved for SARS-CoV-2 with dexamethasone reducing mortality in hospitalised  patients6 
and a number of vaccine trials are currently ongoing.
The viral spike protein is of particular interest from a drug- and vaccine-development perspective due to its 
involvement in recognition and fusion of the virus with its host cell. The spike protein is a heavily glycosylated 
homotrimer, anchored in the viral membrane. It projects from the membrane, giving the virus its characteristic 
crown-like  shape3. The ectodomain of each monomer consists of an N-terminal subunit, S1, comprising two 
domains, S A and S B , followed by an S2 subunit forming a stalk-like structure. Each monomer has a single mem-
brane-spanning segment and a short C-terminal cytoplasmic  tail7. The S1 is involved in recognition of the human 
receptor, angiotensin-converting enzyme 2 (ACE2). This subunit has a closed or down configuration where all 
the domains pack together with their partners from adjacent  polypeptides8,9. However, in order for recognition 
and binding to ACE2 to take place, one of the three S B domains dissociates from its partners and tilts upwards 
into the open or up  configuration8,9. Binding of ACE2 to the open conformation leads to proteolytic cleavage of 
the spike polypeptide between S1 and  S27. S2 then promotes fusion with the host cell membrane leading to viral 
 entry10. In the following we compute the full, structurally-resolved motion pathway from the open to the closed 
structure of the full homo-trimer. We will show that in the closed states, the vibrational motion of the trimer 
closely follows the behavior of an elastic cylinder. In contrast, the most important motion of open structure is 
overall much more flexible and a particularly high mobility in the S B domains can lead to a full closure of the 
trimer. The full structural details is this motion pathway are available via our approach. Drugs that target this 
motion of the spike protein therefore have the potential to prevent infection of host cells.
The main protease of the virus (Mpro ) is another important drug target. M pro is responsible for much of the 
proteolytic cleavage required to obtain the functional proteins needed for viral replication and transcription. 
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These proteins are synthesised in the form of polyproteins which are cleaved to obtain the mature  proteins11. 
M pro is active in its dimeric form but the SARS-CoV M pro is found as a mixture of monomer and dimers in 
 solution12. SARS-CoV M pro has been crystallised in different, pH-dependent conformations suggesting flexibility, 
particularly around the active site. MD simulations support this  flexibility13. The protease is highly conserved in 
all coronaviruses, including SARS-CoV-2, so targeting either dimerization or enzymatic activity may give rise 
to drugs that can target multiple coronaviruses, known and yet  unknown14,15.
Since the discovery of SARS-CoV-2, a plethora of structures have been determined including M pro16 and the 
ectodomain of the spike  protein8,9 as well as other potential drug and vaccine targets. These structures provide 
the opportunity for rational drug design using computational biology to identify candidates and optimise lead 
compounds. However, crystal structures only provide a static picture of proteins, whereas proteins are dynamic. 
This property is often important in drug development. For example, agonists and antagonists often bind different 
conformations of G coupled-protein  receptors17. Flexibility also affects the thermodynamic properties of drug 
 binding18, yet the ability to assess flexibility is often hampered by the long computational times needed for MD 
simulations.
We use a recent protein flexibility modeling  approach19, combining methods for deconstructing a protein 
structure into a network of rigid and flexible units (First)20 with a method that explores the elastic modes of 
motion of this  network21–25, and a geometric modeling of flexible motion (Froda)26,27. The usefulness of this 
approach has recently been shown in a variety of  systems28–32. Methods similar in spirit, exploring flexible motion 
using geometric simulations biased along “easy”directions, have also been implemented using Frodan33 and 
NMSim34. We have performed our analysis through multiple conformational steps starting from the crystal 
structures of SARS-CoV-2-related proteins as currently deposited in the PDB. This results in a comprehensive 
overview of rigidity and the possible flexible motion trajectories of each protein. We emphasize that these tra-
jectories do not represent actual stochastic motion in a thermal bath as a function of time, but rather the pos-
sibility of motion along a set of most relevant low-frequency elastic modes. Each trajectory leads to a gradual 
shift of the protein from the starting structure and this shift may reach an asymptote, where no further motion 
is possible along the initial vector, as a result of steric  constraints31. Energies associated with such a trajectory 
for bonds, angles, electrostatics, and so forth, have be estimated in previous studies of other proteins and shown 
to be consistent and physically plausible. Computing times for the method vary with the size of the proteins, 
but range from minutes to a few hours and are certainly much faster than thermodynamically equilibrated MD 
simulations. Hence, the approach offers the possibility of large-scale screening for protein mobilities.
Results
Protein selection. We have downloaded protein structure files as deposited on the Protein Data  Bank35, 
including all PDB codes that came up when using “SARS-CoV-2” and “Covid-19” as search terms, as well as 
minor variations in spelling. In our first search of April 18th, 2020, this resulted in 133 protein structures. Fur-
ther searches on May 20th and 29th, and August 25th, 2020 gave a total of 287 structures. Many of the structures 
found, as outlined above, have been deposited on the PDB in dimer or trimer forms. Hence one has the choice to 
study the rigidity and motion of the monomer or the dimer/trimer. Clearly, the computational effort for a dimer/
trimer structure is much larger than for a monomer since, in addition to the intra-monomer bond network, 
inter-monomer bonds also need to be taken into account. Furthermore, it is not necessarily clear whether the 
possible motion of a monomer or dimer should be computed to have the most biological relevance. We have cal-
culated the motion of full dimer and trimer structures only for a few selected and biologically most relevant 
such structures while the default results concentrated on the monomers. Nevertheless, we wish to emphasize 
that when results for a certain monomer exist, it should nearly always be possible to also obtain their motion in 
dimer/trimer configuration. For some protein structures, we have found that steric clashes were present in the 
PDB structures that made a flexibility and sometimes even just the rigidity analysis impossible. Usually, this is 
due to a low crystal resolution. A list of all current protein PDB IDs included in this work is given in Table S1.
Rigidity and flexibility. In Figs.  1 and 2 we show examples of different rigidity patterns that emerge 
from the First analysis. In line with previous studies comparing these rigidity patterns across various protein 
 families19, we find that they can be classified into about four types. In Fig. 1a we see that for the crystal structure 
of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain (PDB: 6m3m), the largest rigid cluster 
in the pristine structure, i.e. at Ecut = 0 , largely remains rigid through the dilution process of consecutively low-
ering Ecut values. When bonds are opened the rigid cluster shrinks but the newly independent parts are flexible 
and not part of any new large rigid cluster themselves. Only very small parts of the protein chain break to form 
their own independent rigid structures before at a certain Ecut the whole protein is essentially flexible. We shall 
denote such a behaviour as brick-like. In contrast, in Fig. 1b we observe that for chain A of the co-factor complex 
of NSP7 and the C-terminal domain of NSP8, which forms part of the RNA synthesis machinery from SARS 
CoV-2 (PDB: 6wiq), already the crystal structure has fallen into three independent rigid structures. Opening 
bonds, we find that the largest rigid cluster breaks into 2 rigid structures. Then these now four domains retain 
their character upon opening more and more bonds until they simply dissolve into full flexibility (We use the 
term domain here to denote large regions of a protein connected in the same rigidity cluster. Usually, domains 
in a biological sense are also detected as domains in a rigidity sense as used  here32. However, this relationship is 
not necessarily always the case.).
While brick- and domain-like behaviour is only found occasionally, two further types of rigidity dissolution 
are more prevalent. In Fig. 2a we see that for, e.g. the monomer of the crystal structure of the COVID-19 main 
protease (Mpro ) in apo form (PDB: 6m03), the rigid cluster dominating the crystal structure quickly falls apart 
upon change in Ecut with five newly formed independent rigid clusters emerging towards the C-terminal of the 
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Figure 1.  Examples of rigid cluster decompositions for different SARS-CoV-2 protein structures. (a) Shows 
the cluster decomposition for the crystal structure of the SARS-CoV-2 nucleocapsid protein N-terminal RNA 
binding domain (PDB: 6m3m) while (b) gives chain A of the co-factor complex of NSP7 and the C-terminal 
domain of NSP8 from SARS CoV-2 (PDB: 6wiq). Different rigid clusters of the polypeptide chain appear as 
coloured blocks along the protein chain with each Cα labelled from its N-terminal at 1 to its C-terminal. The 
three columns at the left of each cluster decomposition denote the index of the hydrogen bond to have been 
opened last (with 117 and 124 to total number of H bonds in (a) and (b), respectively), the energy cutoff Ecut (E) 
and the mean number of bonded neighbours 〈r〉 (mean coordination) at that value of Ecut . The label A indicates 
that protein chain A is being considered from the structure. We emphasize that the Ecut scale is not linear since 
new rows are only added when the rigidity of a structure has changed. When the value of Ecut decreases (the 
downward direction points towards larger, negative Ecut magnitudes), rigid clusters break up and flexibility 
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Figure 2.  Examples of rigid cluster decompositions for different SARS-CoV-2 protein structures. (a) Shows 
the monomer of the crystal structure of the COVID-19 main protease in apo form (PDB: 6m03) and (b) 
gives results for chain A of a complex resulting from the reaction between the SARS-CoV main protease and 
a carbamate (PDB: 6y7m). Distinct rigid clusters of the polypeptide chain appear as coloured blocks along 
the protein chain with each Cα labelled from its N-terminal at 1 (left edge) to its C-terminal (right edge). The 
coloring and choice of blocks follows the same logic as detailed in Fig. 1 except that the left most data columns 
are not shown for clarity. The energy cutoff Ecut decreases in the downward direction towards larger, more 
negative Ecut magnitudes; rigid clusters break up and more of the chain becomes flexible.
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protein chain. These new clusters remain stable to the opening of further bonds, even when the remnants of the 
original rigid cluster has become fully flexible. Such a behaviour relies on a certain critical Ecut value to domi-
nate the rigidity dissolution and is reminiscent of so-called first-order phase transitions in statistical physics. 
Hence this rigidity-type is usually denoted as 1st order19. The behaviour seen in 2b for the crystal structure of the 
complex resulting from the reaction between the SARS-CoV main protease and tert-butyl (1-((S)-3-cyclohexyl-
1-(((S)-4-(cyclopropylamino)-3,4-dioxo-1-((S)-2-oxopyrrolidin-3-yl)butan-2-yl)amino)-1-oxopropan-2-yl)-
2-oxo-1,2-dihydropyridin-3-yl)carbamate (PDB: 6y7m) is markedly different. Here, there are many values of 
Ecut where large parts of the original rigid structure break off one after another so that towards the end of the 
bond-opening process, the original cluster is still present, but no longer dominates the rigidity pattern. This 
behaviour is called 2nd order19.
In Table S1, we have indicated the classification for each protein structure into the four classes. Obviously, 
this classification is not perfect and there are also sometimes intermediate rigidity patterns. Nevertheless, this 
rigidity classification already provides a first insight into the possible flexibility and range of motion for each 
structure. It should be clear, that a brick-like rigidity shows the least flexibility until it dissolves completely. On 
the other hand, for domain-like structures, one can expect possible intra-domain motion while inter-domain 
motion might be harder to spot. Similarly, for a 1st-order rigidity, one would expect little dynamic mobility until 
the “transition” value for Ecut has been reached, although high levels of flexibility should be possible afterwards. 
Lastly, a protein with 2nd-order rigidity should have the most complex behaviour in terms of flexibility since 
new possible mobility can be expected throughout the range of Ecut values.
Protein mobility. For each value of Ecut , the First analysis has provided us with a map of rigid and flexible 
regions in a given crystal structure. We can now translate this into propensity of motion by allowing the flexible 
parts to move perturbatively, subject to full bonding and steric constraints (see “Methods” section). Moving 
along directions proposed by an elastic normal model analysis of the crystal structure, we can therefore con-
struct possible motion trajectories that are fully consistent with the bond network and steric constraints. Each 
trajectory corresponds to one such normal mode, denoted m7 up to m12 for the first low-frequency non-trivial 
such modes, as well as the chosen Ecut value. Generally, a larger value of |Ecut| implies less rigidity and results 
in larger scale flexible motion. In Figs. 3 and 4 we give examples of such motion trajectories. Figure 3 shows a 
monomer of the SARS-CoV-2 spike glycoprotein (closed state) (PDB code:  6vxx9). We can see that there is a 
good range of motion from the crystal structure when following the normal mode modes into either positive or 
negative changes along the mode vector. Figure 4 shows the motion for the dimer structure of the SARS-CoV-2 
main protease (PDB code: 6lu7, in complex with inhibitor N3. We have removed the inhibitor in the motion 
analysis here)16. Again, one can see considerable motion, although due to the complexity of the structure, it is 
Figure 3.  Example of flexible motion for mode m7 of the SARS-CoV-2 spike ecto domain (PDB: 6vxx) 
monomer at Ecut = 0.5 kcal/mol with chain A denoted by yellow with its extreme structural positions 
superimposed and colored light orange/orange. The arrow indicates the range of movement for the dominant α
-helix structure in the spike ecto domain, from negative to positive movement. The smaller protein structures 
surrounding the large one show the initial (crystal) structure as well as the extremes ( + , –) along the possible 
motion directions for m7 in the same colors as in the superimposed structure.
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difficult to distinguish individual movement patterns from such a frozen image. Much better insight can be 
gained when watching for full range of motion as a movie. Direct access to the movie for the spike ecto domain 
monomer (6vxx) is provided via Ref.36, while the motion of the main protease dimer can be viewed at Ref.37. 
We have made a dedicated web download  page38 where movies for the complete set of PDB codes as given in 
Table S1 are publicly available. The movies are being offered for various modes m7 to m12 as well as Ecut values, 
at least containing results for Ecut = −1 kcal/mol , −2 kcal/mol and −3 kcal/mol , respectively. In addition, the 
site includes the rigidity resolutions discussed above and all intermediate structures needed to make the mov-
ies. This allows for the calculation of relative distances and other such structural measures along each motion 
trajectory as desired. For a detailed analysis of the SARS-CoV-2 main protease with similar methods, we refer 
the reader to Ref.39.
SARS‑CoV‑2 spike ecto domain structures. The trans-membrane spike glycoprotein mediates entry 
into host  cells8,9. As such, it is a “main target for neutralizing antibodies upon infection and the focus of thera-
peutic and vaccine design”9. It forms homotrimers protruding from the viral  surface3. Up to the end of May 2020, 
3 structures of the trans-membrane spike glycoprotein have been deposited in the PDB. These transmission 
electron cryomicroscopy (cryo-EM) studies have led to structures with PDB codes  6vsb8,  6vxx9 and  6vyb9 now 
being available. With RMS resolution of 3.5 Å, 6vsb has a slightly lower resolution than 6vxx at 2.8 Å and 6byv 
at 3.2 Å. In the following, we shall discuss the resulting rigidity and flexibility properties of these three structures 
in their full trimer form. Results for individual monomer rigidities, as given in Fig. 3, are also available at Ref.38.
Prefusion SARS‑CoV‑2 spike glycoprotein with a single receptor‑binding domain open. The rigidity pattern of 
the homotrimer for this structure (PDB: 6vsb, 440.69 kDa , 22854 atoms, 2905 residues) is dominated by a large 
rigid cluster encompassing most of the trimer structure except for a region from roughly residue 330 to resi-
due 525 (With nearly 3000 residues in the structure of the trimer, is it impossible to capture the behaviour in a 
Figure 4.  Example of flexible motion for mode m7 of the dimer of main protease (PDB: 6lu7) at 
Ecut = 2 kcal/mol . The crystal structure of the dimer is superimposed with its extreme structural positions 
according to mode m7 . Chain A is denoted yellow and its extremal structures colored as in Fig. 3 light orange/
orange; chain B is indicated in blue with extremal positions in light and dark blue. The smaller protein structures 
show the initial (crystal) structure as well as the extremes ( + , –) along the possible motion directions for m7 in 
the same colors as in the superimposed structure.
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single figure that at the same time would allow the reader to see enough detail. The reader is referred to Ref.38 
for access to the electronic images.). This corresponds to the S B domain of S1 in each monomer. In the trimer 
configuration, it is known that one of the S B domains can change from the closed to an open  configuration8. At 
|Ecut| = 0.016 kcal/mol , the 6vsb structure of the trimer breaks into many different rigid parts, but the original 
large cluster remains a dominating feature across the rigidity dilution plot. A motion analysis does not compute 
but breaks with bad sterics, apparently due to the comparably low resolution of the crystal structure.
Mobility of the SARS‑CoV‑2 spike glycoprotein (closed state). For the closed state structure (6vxx, 438.53 kDa , 
Atom Count: 23694 atoms, 2916 residues) of the SARS-CoV-2 spike glycoprotein, the rigidity pattern is again 
“brick”-like and the whole of the crystal structure is part of a single cluster. At |Ecut| = 0.022 kcal/mol , there is 
a first order break of the large rigid cluster into dozens of smaller rigid units. Nevertheless, the original cluster 
retains a good presence in each chain of the trimer. We are now able to produce motion studies for the full set 
of modes m7 to m12 and various Ecut’s. In Figs. 5 and 6 we show the results, again using the structures for the 
extreme ranges of the motion as in Fig. 3. Figure 6 shows a view from the top while Fig. 5 gives a view from the 
side of the spike protein. Both views are chosen similar to those given in Ref.9. The movies corresponding to 
Figs. 5 and 6 can be viewed at Refs.40,41, respectively. Looking at the whole range of modes and Ecut ’s computed, 
we find that the motion is very reminiscent of the vibrational excitations of a rigid cone or cylinder. There is twist 
motion around the central axis, bending of the trimer along the central axis, relative twist motion of 2 chains 
relative to the remaining chain (c.p. Fig. 5), etc. At m12 (with |Ecut| = 2 kcal/mol) , large scale motion has already 
stopped and one only observes smaller scale motion in flexible parts of the trimer chains. Overall, this behaviour 
is very consistent with the elastic behaviour of a “closed”  structure9 such as a cone or cylinder. 
Mobility of the SARS‑CoV‑2 spike glycoprotein (open state). We now turn to the last SARS-CoV-2 spike ecto 
domain structure (6vyb, 437.65 kDa , 22365 atoms, 2875 residues)9. This structure is in the open configura-
Figure 5.  Top view of the spike ecto domain in the closed configuration (6vxx)9 for mode m7 motion at 
Ecut = 2 kcal/mol for the whole trimer. The secondary protein structure is highlighted by the chosen “cartoon” 
representation. Colors yellow, blue and red denote chains A, B, and C, respectively, while color combinations 
light orange/orange, pink/purple and light blue/dark blue show the extreme structural positions for the 
movements along the normal mode m7 at Ecut = 2 kcal/mol . As in Fig. 3, the smaller protein structures show 
the initial (crystal) structure as well as the extremes ( + , –) along the possible motion directions for m7 in the 
same colors as in the superimposed structure.
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tion similar to the conformation seen in  6vsb8. The structure is shown in top view in Fig. 7 and in side view in 
Fig. 8. From the rigidity plots we find, in addition to the largest rigid cluster, already for the crystal structure 
at |Ecut| = 0 kcal/mol a second rigid cluster, also roughly spanning from residue 330 to 525. Again, this region 
identifies the S B domain as in the 6vsb structure. Compared to the closed state (6vxx), we see that this cluster 
has more internal structure, i.e. consists of more flexible parts in the S B region from 330 to 525 and also seems to 
fall apart upon further increasing the |Ecut| value. This suggests that it is more flexible as a whole. Upon motion 
simulation,  see42,43 for side and top views, we observe a very high mobility in that prominent S B subdomain. 
Starting from the crystal structure, we find for |Ecut| = 1 kcal/mol a clear further opening towards a negative 
Froda mode, m7 , while in the other, positive direction of m7 , the structure can again close the trimer. The dis-
tance range of the motion can be expressed as follows: the distance from residue 501 in the middle of the central 
β-sheet of the S B to the most opened conformation is 57 Å while distance to the same residue in the most closed 
conformation is 28 Å. The distance from open to closed is 69 Å. Hence the motion simulation adds additional 
insight into the distinction between the open (6vyb) and the closed (6vxx) structures while also showing that 
a transition from open to closed is indeed possible. As stated in Ref.9, this interplay of closing and opening is 
expected to be central to the viral entry into the human cell.  
Other SARS‑CoV‑2 structures of interest. Similar results have been  obtained38 for the other about 300 
Covid-19 structures thus far deposited in the PDB. For example, from those structures deposited from late May 
to August 2020, the nsp7-nsp8c complex (PDB code: 6m5i)44 is potentially interesting as this complex is part of 
the RNA transcription and replication machinery. The motion of the hetero dimer shows an intriguing move-
ment restricted to just one of the total seven α helices. The motion of ORF3a (PDB code: 6xdc)45, a putative ion 
channel, might be important in understanding the inflammatory response resulting from Covid-19 infection, 
i.e. as deletion has been shown to reduce viral titer. We find considerable flexibility in the homo dimer structure 
between the α-helix-rich and the β-sheet regions. On the other hand, SARS-CoV-2 Orf9b, which potentially 
suppresses the interferon response upon infection leading to a less effective immune  response46, shows very little 
flexibility (PDB code: 6z4u)47.
Figure 6.  Side views of motion in the spike ecto domain in closed configuration (6vxx)9 for m7 motion at 
Ecut = 2 kcal/mol for the whole trimer. The secondary protein structure is highlighted by the chosen “cartoon” 
representation. As in Fig. 5, colors yellow, blue and red denote chains A, B, and C, respectively, while color 
combinations light orange/orange, pink/purple and light blue/dark blue show the extreme structural positions 
for the movements along m7 . The smaller protein structures show the initial (crystal) structure as well as the 
extremes ( + , –) along m7 in the same colors as in the superimposed structure.
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Discussion
SARS-CoV-2 infectivity is dependent on binding of the spike protein to ACE2. This binding is only possible 
when the spike protein is in the open conformation. Structures of both the open and closed conformation have 
already been determined and the flexibility of the S B domain inferred from these static  structures8,9. The spike 
trimer consists of almost 3000 amino acids; it not an easy target for dynamics simulations due to its size. In the 
open structures (6vsb and 6vyb) the S B domain is easily identifiable in the rigidity analysis as a separate cluster 
to the rest of the trimer. This shows that the domain has increased flexibility. We can clearly observe the hinge 
movement of the S B domain in the open configuration (6vyb), with the S B domain moving back into the closed 
configuration. The range of movement from the most opened to the most closed conformation can be measured 
to be quite large. The flexibility within the S B domain itself during the hinge movement is also seen to be consid-
erable. All these findings suggest that the S B domain of the spike protein has the necessary flexibility to attach 
itself readily to ACE2. However, when starting from the closed structure (6vxx), we do not see an opening. This 
suggests possibly stronger bonds and steric constraints which need to be overcome before the structure is able 
to open up. Nevertheless, to our knowledge this is the first time the hinge motion of the S B domain has been 
predicted solely based on the dynamics of a structure. In principle, the full structural information provided in 
our download  site38 can be used to perform possible docking studies with ligands of different sizes. These inter-
mediate conformations can also be used as convenient starting points for further MD-based dynamics studies to 
evaluate thermodynamic properties of the structures. This shows the power of FIRST and FRODA to complement 
structure determinations and MD simulations to make valid predictions about the dynamics of proteins. Similarly 
detailed structural analyses and further MD work is also possible for the other structures included in this work. 
The classification of the protein structures into four types of dynamics provides information about the level of 
flexibility of a protein which is relevant to drug discovery. For more detailed information rigidity dilution plots 
and motion movies are available for download at Ref.38. In addition, the code underlying our study is accessible 
at Ref.48 and implemented in a free web server at Ref.49.
Figure 7.  Possible motion along mode m7 at Ecut = 1 kcal/mol in the open spike ecto domain (6vyb)9 when in 
view from the top. Colors for the superimposed structure are chosen identical to Figs. 5 and 6. As in Fig. 3, the 
arrows indicate the range of motion for chain B (blue shades) and also for chain C (reds). The initial (crystal) 
structure as well as the extremes ( + , –) along m7 in the same colors as in the superimposed structure are shown 
in the three smaller proteins.
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Methods
Rigidity analysis. In each case we start the rigidity, flexibility and mobility modelling with a given protein 
crystal structure file in PDB .pdb format. Hydrogen atoms absent from the PDB crystal structures are added 
using the software Reduce50. Alternate conformations that might be present in the protein structure file are 
removed if needed and the hydrogen atoms are renumbered in PyMol51. We find that for some protein struc-
tures the addition of hydrogen atoms is not possible without steric clashes. Consequently, identification of a 
viable structure and its continued analysis is not possible. These proteins are labelled in Table S1. We observe five 
structures which exhibit such steric clashes.
For the remaining proteins we produce the “rigidity dilution” or rigid cluster decomposition (RCD) plot 
using First20. The plots show the dependence of the protein rigidity on an energy cutoff parameter, Ecut < 0 . 
It parametrizes a bonding range cutoff based on a Mayo  potential52,53 such that larger (negative) values of Ecut 
correspond to more open bonds, i.e. a smaller set of hydrogen bonds to be included in the rigidity analysis.
Elastic network modes. We obtain the normal modes of motion using elastic network modelling (ENM)54 
implemented in the ElNemo  software23,24. This generates a set of elastic eigenmodes and associated eigenfre-
quencies for each protein. The low-frequency modes are expected to have the largest motion amplitudes and 
thus be most significant for large conformational changes. The six lowest-frequency modes (modes 1–6) are just 
trivial combinations of rigid-body translations and rotations of the entire protein. Here we consider the six low-
est-frequency non-trivial modes, that is, modes 7–12 for each protein. We denote these modes as m7 , m8 , . . . , m12.
Mobility simulations. The modes are next used as starting directions for a geometric simulation, imple-
mented in the Froda  module26 within First. This explores the flexible motion available to a protein within 
a given pattern of rigidity and flexibility. Froda then reapplies bonding and steric constraints to produce an 
acceptable new conformation. Since the displacement from one conformation to the next is typically small, we 
Figure 8.  Possible motion along mode m7 at Ecut = 1 kcal/mol in the open spike ecto domain (6vyb)9 in side 
view. Colors are chosen identical to Fig. 5. As in Figs. 3 and 7, the arrow shows the range of motion for chain 
B (blue shades). The initial (crystal) structure as well as the extremes ( + , –) along m7 are shown in the three 
smaller proteins, using the same colors as in the superimposed structure.
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only record every 50th conformation. Typically the computation continues for several thousand conformations. 
A mode run is considered complete when no further projection along the mode eigenvector is possible (due to 
steric clashes or bonding constraints). Such a situation manifests itself in slow generation of new conformations. 
We have performed a Froda mobility simulation for each protein at several selected values of Ecut . This allows 
us to study each protein at varying stages of its bond network, roughly corresponding to changing environmental 
conditions, such as different temperatures as well as changes in the solution environments. In a previous publica-
tion, we discussed the criteria for a robust selection of Ecut53. Ideally, for each protein structure, a bespoke set of 
Ecut values should be found, with the RCD plots providing good guidance on which Ecut values to select. Clearly, 
for a large-scale study as presented here, this is not readily possible due to time constraints. Instead, we have 
chosen Ecut = −1 kcal/mol,−2 kcal/mol and −3 kcal/mol for each protein. These values have been used before 
in a multi-domain protein with 22 kDa and shown to reproduce well the behaviour of (i) a mostly rigid protein 
at Ecut = −1 kcal/mol , (ii) a protein with large flexible substructures/domains at Ecut = −2 kcal/mol and (iii) a 
protein with mostly flexible parts connecting smaller sized rigid subunits at Ecut = −3 kcal/mol31,53. In addition, 
we have also performed the analysis at other values of Ecut when upon inspection of the RCD plots it was seen 
that the standard values (i)–(iii) would not be sufficient. The exact values used are given in Table S1.
We emphasize that these trajectories do not represent actual stochastic motion in a thermal bath as a func-
tion of time, but rather the possibility of motion along the most relevant elastic modes. Each trajectory leads to 
a gradual shift of the protein from the starting structure. This shift eventually reaches an asymptote, where no 
further motion is possible along the initial vector, as a result of steric constraints. Energies associated with such 
a trajectory for bonds, angles, electrostatics, and so forth, can be estimated and shown to be consistent and 
physically  plausible31.
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